Physician profile
Khalid George
NPI 1275965287
$2,859.03
in general payments reported to CMS, 2019-2025
27 companies · $21.54 in 2025
The $21.54 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $302 · 2021: $458 · 2022: $368 · 2023: $637 · 2024: $323 · 2025: $21.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,309.96 | 2019-2024 | |
| Gilead Sciences, INC. | $243.20 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $235.97 | 2021-2024 | Dificid |
| Dova Pharmaceuticals | $122.50 | 2019 | |
| Celgene Corporation | $112.97 | 2021-2023 | Zeposia |
| Janssen Biotech, INC. | $99.00 | 2019 | |
| Astellas Pharma US INC | $69.95 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $65.43 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $60.16 | 2019-2023 | Gattex |
| Nestle Healthcare Nutrition INC. | $49.81 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.39 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $46.27 | 2023-2024 | Ocaliva |
| Braintree Laboratories, INC. | $45.22 | 2023 | Sutab |
| Vivus LLC | $43.77 | 2021-2022 | |
| Exact Sciences Corporation | $39.13 | 2023 | Cologuard Collection Kit |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36.06 | 2023 | Interstim, Nuro |
| Daiichi Sankyo INC. | $31.77 | 2019-2020 | |
| Axonics, INC. | $27.06 | 2023 | Axonics |
| Sumitomo Pharma America, INC. | $26.60 | 2023 | Gemtesa |
| Hologic Sales and Service, LLC | $23.32 | 2023 | Coolseal Generator |
| Endo Pharmaceuticals INC. | $23.31 | 2020 | |
| Boston Scientific Corporation | $21.54 | 2025 | Resolution 360 Clip |
| Olympus America INC. | $19.62 | 2020 | |
| Pfizer INC. | $18.13 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.74 | 2024 | Dupixent |
| Ethicon US, LLC | $14.32 | 2019 | |
| Allergan, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.